nodes	percent_of_prediction	percent_of_DWPC	metapath
Glipizide—KCNJ11—epilepsy syndrome	0.382	1	CbGaD
Glipizide—CYP2C9—Trimethadione—epilepsy syndrome	0.0263	0.077	CbGbCtD
Glipizide—CYP2C9—Fosphenytoin—epilepsy syndrome	0.0247	0.0724	CbGbCtD
Glipizide—CYP2C9—Carbamazepine—epilepsy syndrome	0.0177	0.052	CbGbCtD
Glipizide—CYP2C9—Primidone—epilepsy syndrome	0.0166	0.0485	CbGbCtD
Glipizide—CYP3A4—Oxcarbazepine—epilepsy syndrome	0.0164	0.0481	CbGbCtD
Glipizide—CYP2C9—Phenytoin—epilepsy syndrome	0.0159	0.0466	CbGbCtD
Glipizide—CYP3A4—Felbamate—epilepsy syndrome	0.0153	0.0448	CbGbCtD
Glipizide—CYP3A4—Trimethadione—epilepsy syndrome	0.0153	0.0448	CbGbCtD
Glipizide—CYP2C9—Propofol—epilepsy syndrome	0.0148	0.0435	CbGbCtD
Glipizide—CYP3A4—Fosphenytoin—epilepsy syndrome	0.0144	0.0421	CbGbCtD
Glipizide—CYP2C9—Phenobarbital—epilepsy syndrome	0.0142	0.0416	CbGbCtD
Glipizide—CYP2C9—Diazepam—epilepsy syndrome	0.0134	0.0394	CbGbCtD
Glipizide—CYP3A4—Clonazepam—epilepsy syndrome	0.013	0.0381	CbGbCtD
Glipizide—CYP3A4—Clobazam—epilepsy syndrome	0.0124	0.0365	CbGbCtD
Glipizide—CYP2C9—Valproic Acid—epilepsy syndrome	0.0106	0.0311	CbGbCtD
Glipizide—CYP3A4—Rufinamide—epilepsy syndrome	0.0106	0.031	CbGbCtD
Glipizide—CYP3A4—Carbamazepine—epilepsy syndrome	0.0103	0.0302	CbGbCtD
Glipizide—CYP3A4—Primidone—epilepsy syndrome	0.00963	0.0282	CbGbCtD
Glipizide—CYP3A4—Phenytoin—epilepsy syndrome	0.00925	0.0271	CbGbCtD
Glipizide—CYP3A4—Propofol—epilepsy syndrome	0.00863	0.0253	CbGbCtD
Glipizide—CYP3A4—Phenobarbital—epilepsy syndrome	0.00824	0.0242	CbGbCtD
Glipizide—CYP3A4—Acetazolamide—epilepsy syndrome	0.00824	0.0242	CbGbCtD
Glipizide—CYP3A4—Midazolam—epilepsy syndrome	0.00813	0.0238	CbGbCtD
Glipizide—CYP3A4—Diazepam—epilepsy syndrome	0.00782	0.0229	CbGbCtD
Glipizide—CYP3A4—Zonisamide—epilepsy syndrome	0.00763	0.0224	CbGbCtD
Glipizide—CYP3A4—Valproic Acid—epilepsy syndrome	0.00616	0.0181	CbGbCtD
Glipizide—CYP3A4—Topiramate—epilepsy syndrome	0.00556	0.0163	CbGbCtD
Glipizide—PPARG—forelimb—epilepsy syndrome	0.00257	0.205	CbGeAlD
Glipizide—ABCC8—brainstem—epilepsy syndrome	0.00079	0.0632	CbGeAlD
Glipizide—ABCC8—forebrain—epilepsy syndrome	0.000762	0.061	CbGeAlD
Glipizide—ABCC8—telencephalon—epilepsy syndrome	0.000701	0.0561	CbGeAlD
Glipizide—Gliquidone—KCNJ11—epilepsy syndrome	0.000646	0.132	CrCbGaD
Glipizide—PPARG—forebrain—epilepsy syndrome	0.000582	0.0466	CbGeAlD
Glipizide—ABCC8—medulla oblongata—epilepsy syndrome	0.000551	0.0441	CbGeAlD
Glipizide—Tolazamide—KCNJ11—epilepsy syndrome	0.000516	0.106	CrCbGaD
Glipizide—ABCC8—midbrain—epilepsy syndrome	0.000503	0.0403	CbGeAlD
Glipizide—ABCC8—spinal cord—epilepsy syndrome	0.000491	0.0393	CbGeAlD
Glipizide—KCNJ11—head—epilepsy syndrome	0.000474	0.0379	CbGeAlD
Glipizide—Glisoxepide—KCNJ11—epilepsy syndrome	0.000467	0.0955	CrCbGaD
Glipizide—Glimepiride—KCNJ11—epilepsy syndrome	0.00046	0.0941	CrCbGaD
Glipizide—KCNJ11—nervous system—epilepsy syndrome	0.000449	0.036	CbGeAlD
Glipizide—ABCC8—head—epilepsy syndrome	0.000436	0.0349	CbGeAlD
Glipizide—KCNJ11—central nervous system—epilepsy syndrome	0.000432	0.0346	CbGeAlD
Glipizide—KCNJ11—cerebellum—epilepsy syndrome	0.000423	0.0338	CbGeAlD
Glipizide—ABCC8—nervous system—epilepsy syndrome	0.000414	0.0331	CbGeAlD
Glipizide—ABCC8—central nervous system—epilepsy syndrome	0.000398	0.0319	CbGeAlD
Glipizide—ABCC8—cerebellum—epilepsy syndrome	0.000389	0.0312	CbGeAlD
Glipizide—Gliclazide—KCNJ11—epilepsy syndrome	0.000371	0.0759	CrCbGaD
Glipizide—KCNJ11—brain—epilepsy syndrome	0.000343	0.0275	CbGeAlD
Glipizide—PPARG—head—epilepsy syndrome	0.000333	0.0267	CbGeAlD
Glipizide—Tolbutamide—SLCO1A2—epilepsy syndrome	0.000318	0.065	CrCbGaD
Glipizide—ABCC8—brain—epilepsy syndrome	0.000316	0.0253	CbGeAlD
Glipizide—PPARG—nervous system—epilepsy syndrome	0.000316	0.0253	CbGeAlD
Glipizide—PPARG—central nervous system—epilepsy syndrome	0.000304	0.0243	CbGeAlD
Glipizide—Chlorpropamide—KCNJ11—epilepsy syndrome	0.000288	0.059	CrCbGaD
Glipizide—Gliclazide—VEGFA—epilepsy syndrome	0.000288	0.0588	CrCbGaD
Glipizide—Tolbutamide—KCNJ11—epilepsy syndrome	0.000281	0.0575	CrCbGaD
Glipizide—PPARG—brain—epilepsy syndrome	0.000241	0.0193	CbGeAlD
Glipizide—Glyburide—SLCO1A2—epilepsy syndrome	0.00022	0.045	CrCbGaD
Glipizide—Glyburide—KCNJ11—epilepsy syndrome	0.000195	0.0398	CrCbGaD
Glipizide—CYP3A4—nervous system—epilepsy syndrome	0.000141	0.0113	CbGeAlD
Glipizide—Gliclazide—CYP2C19—epilepsy syndrome	0.000139	0.0285	CrCbGaD
Glipizide—CYP3A4—central nervous system—epilepsy syndrome	0.000136	0.0109	CbGeAlD
Glipizide—Chlorpropamide—CYP2C19—epilepsy syndrome	0.000108	0.0222	CrCbGaD
Glipizide—Tolbutamide—CYP2C19—epilepsy syndrome	0.000106	0.0216	CrCbGaD
Glipizide—Glyburide—ABCC2—epilepsy syndrome	0.000105	0.0215	CrCbGaD
Glipizide—Glyburide—ABCG2—epilepsy syndrome	9.31e-05	0.019	CrCbGaD
Glipizide—Gliclazide—ALB—epilepsy syndrome	7.73e-05	0.0158	CrCbGaD
Glipizide—Glyburide—CYP2C19—epilepsy syndrome	7.32e-05	0.015	CrCbGaD
Glipizide—Hypersensitivity—Oxcarbazepine—epilepsy syndrome	7.03e-05	0.000398	CcSEcCtD
Glipizide—Malaise—Pregabalin—epilepsy syndrome	7.03e-05	0.000398	CcSEcCtD
Glipizide—Nausea—Propofol—epilepsy syndrome	7.02e-05	0.000398	CcSEcCtD
Glipizide—Tension—Gabapentin—epilepsy syndrome	7.01e-05	0.000397	CcSEcCtD
Glipizide—Vomiting—Fosphenytoin—epilepsy syndrome	7.01e-05	0.000397	CcSEcCtD
Glipizide—Diarrhoea—Felbamate—epilepsy syndrome	7.01e-05	0.000397	CcSEcCtD
Glipizide—Vertigo—Pregabalin—epilepsy syndrome	7e-05	0.000397	CcSEcCtD
Glipizide—Abdominal pain—Lamotrigine—epilepsy syndrome	7e-05	0.000397	CcSEcCtD
Glipizide—Dizziness—Diazepam—epilepsy syndrome	7e-05	0.000396	CcSEcCtD
Glipizide—Syncope—Pregabalin—epilepsy syndrome	6.99e-05	0.000396	CcSEcCtD
Glipizide—Leukopenia—Pregabalin—epilepsy syndrome	6.97e-05	0.000395	CcSEcCtD
Glipizide—Rash—Fosphenytoin—epilepsy syndrome	6.95e-05	0.000394	CcSEcCtD
Glipizide—Dermatitis—Fosphenytoin—epilepsy syndrome	6.95e-05	0.000394	CcSEcCtD
Glipizide—Nervousness—Gabapentin—epilepsy syndrome	6.94e-05	0.000393	CcSEcCtD
Glipizide—Asthenia—Clonazepam—epilepsy syndrome	6.93e-05	0.000393	CcSEcCtD
Glipizide—Rhinitis—Topiramate—epilepsy syndrome	6.92e-05	0.000392	CcSEcCtD
Glipizide—Headache—Fosphenytoin—epilepsy syndrome	6.91e-05	0.000391	CcSEcCtD
Glipizide—Hepatitis—Topiramate—epilepsy syndrome	6.91e-05	0.000391	CcSEcCtD
Glipizide—Thrombocytopenia—Valproic Acid—epilepsy syndrome	6.89e-05	0.00039	CcSEcCtD
Glipizide—Asthenia—Phenytoin—epilepsy syndrome	6.88e-05	0.00039	CcSEcCtD
Glipizide—Nausea—Midazolam—epilepsy syndrome	6.87e-05	0.000389	CcSEcCtD
Glipizide—Hypoaesthesia—Topiramate—epilepsy syndrome	6.87e-05	0.000389	CcSEcCtD
Glipizide—Muscle spasms—Gabapentin—epilepsy syndrome	6.87e-05	0.000389	CcSEcCtD
Glipizide—Diarrhoea—Zonisamide—epilepsy syndrome	6.86e-05	0.000389	CcSEcCtD
Glipizide—Pharyngitis—Topiramate—epilepsy syndrome	6.85e-05	0.000388	CcSEcCtD
Glipizide—Loss of consciousness—Pregabalin—epilepsy syndrome	6.85e-05	0.000388	CcSEcCtD
Glipizide—Asthenia—Oxcarbazepine—epilepsy syndrome	6.85e-05	0.000388	CcSEcCtD
Glipizide—Pruritus—Clonazepam—epilepsy syndrome	6.83e-05	0.000387	CcSEcCtD
Glipizide—Vomiting—Vigabatrin—epilepsy syndrome	6.83e-05	0.000387	CcSEcCtD
Glipizide—Hyperhidrosis—Valproic Acid—epilepsy syndrome	6.8e-05	0.000385	CcSEcCtD
Glipizide—Pruritus—Phenytoin—epilepsy syndrome	6.79e-05	0.000385	CcSEcCtD
Glipizide—Nausea—Levetiracetam—epilepsy syndrome	6.79e-05	0.000384	CcSEcCtD
Glipizide—Rash—Vigabatrin—epilepsy syndrome	6.78e-05	0.000384	CcSEcCtD
Glipizide—Dizziness—Felbamate—epilepsy syndrome	6.77e-05	0.000384	CcSEcCtD
Glipizide—Dermatitis—Vigabatrin—epilepsy syndrome	6.77e-05	0.000384	CcSEcCtD
Glipizide—Pruritus—Oxcarbazepine—epilepsy syndrome	6.75e-05	0.000383	CcSEcCtD
Glipizide—Hypersensitivity—Carbamazepine—epilepsy syndrome	6.75e-05	0.000382	CcSEcCtD
Glipizide—Vision blurred—Gabapentin—epilepsy syndrome	6.73e-05	0.000382	CcSEcCtD
Glipizide—Headache—Vigabatrin—epilepsy syndrome	6.73e-05	0.000381	CcSEcCtD
Glipizide—Hypertension—Pregabalin—epilepsy syndrome	6.73e-05	0.000381	CcSEcCtD
Glipizide—Vomiting—Diazepam—epilepsy syndrome	6.73e-05	0.000381	CcSEcCtD
Glipizide—Anorexia—Valproic Acid—epilepsy syndrome	6.71e-05	0.00038	CcSEcCtD
Glipizide—Tremor—Gabapentin—epilepsy syndrome	6.69e-05	0.000379	CcSEcCtD
Glipizide—Rash—Diazepam—epilepsy syndrome	6.67e-05	0.000378	CcSEcCtD
Glipizide—Dermatitis—Diazepam—epilepsy syndrome	6.66e-05	0.000378	CcSEcCtD
Glipizide—Visual impairment—Topiramate—epilepsy syndrome	6.65e-05	0.000377	CcSEcCtD
Glipizide—Arthralgia—Pregabalin—epilepsy syndrome	6.63e-05	0.000376	CcSEcCtD
Glipizide—Myalgia—Pregabalin—epilepsy syndrome	6.63e-05	0.000376	CcSEcCtD
Glipizide—Ill-defined disorder—Gabapentin—epilepsy syndrome	6.63e-05	0.000376	CcSEcCtD
Glipizide—Dizziness—Zonisamide—epilepsy syndrome	6.63e-05	0.000376	CcSEcCtD
Glipizide—Headache—Diazepam—epilepsy syndrome	6.63e-05	0.000376	CcSEcCtD
Glipizide—Anxiety—Pregabalin—epilepsy syndrome	6.61e-05	0.000375	CcSEcCtD
Glipizide—Diarrhoea—Clonazepam—epilepsy syndrome	6.61e-05	0.000375	CcSEcCtD
Glipizide—Asthenia—Carbamazepine—epilepsy syndrome	6.57e-05	0.000372	CcSEcCtD
Glipizide—Diarrhoea—Phenytoin—epilepsy syndrome	6.57e-05	0.000372	CcSEcCtD
Glipizide—Discomfort—Pregabalin—epilepsy syndrome	6.55e-05	0.000371	CcSEcCtD
Glipizide—Nausea—Fosphenytoin—epilepsy syndrome	6.55e-05	0.000371	CcSEcCtD
Glipizide—Diarrhoea—Oxcarbazepine—epilepsy syndrome	6.53e-05	0.00037	CcSEcCtD
Glipizide—Hypersensitivity—Lamotrigine—epilepsy syndrome	6.52e-05	0.00037	CcSEcCtD
Glipizide—Vomiting—Felbamate—epilepsy syndrome	6.51e-05	0.000369	CcSEcCtD
Glipizide—Pruritus—Carbamazepine—epilepsy syndrome	6.48e-05	0.000367	CcSEcCtD
Glipizide—Rash—Felbamate—epilepsy syndrome	6.46e-05	0.000366	CcSEcCtD
Glipizide—Eye disorder—Topiramate—epilepsy syndrome	6.45e-05	0.000366	CcSEcCtD
Glipizide—Dermatitis—Felbamate—epilepsy syndrome	6.45e-05	0.000365	CcSEcCtD
Glipizide—Malaise—Gabapentin—epilepsy syndrome	6.44e-05	0.000365	CcSEcCtD
Glipizide—Vertigo—Gabapentin—epilepsy syndrome	6.42e-05	0.000364	CcSEcCtD
Glipizide—Headache—Felbamate—epilepsy syndrome	6.41e-05	0.000363	CcSEcCtD
Glipizide—Confusional state—Pregabalin—epilepsy syndrome	6.41e-05	0.000363	CcSEcCtD
Glipizide—Musculoskeletal discomfort—Valproic Acid—epilepsy syndrome	6.41e-05	0.000363	CcSEcCtD
Glipizide—Flushing—Topiramate—epilepsy syndrome	6.41e-05	0.000363	CcSEcCtD
Glipizide—Syncope—Gabapentin—epilepsy syndrome	6.41e-05	0.000363	CcSEcCtD
Glipizide—Leukopenia—Gabapentin—epilepsy syndrome	6.4e-05	0.000362	CcSEcCtD
Glipizide—Dizziness—Clonazepam—epilepsy syndrome	6.39e-05	0.000362	CcSEcCtD
Glipizide—Nausea—Vigabatrin—epilepsy syndrome	6.38e-05	0.000362	CcSEcCtD
Glipizide—Vomiting—Zonisamide—epilepsy syndrome	6.37e-05	0.000361	CcSEcCtD
Glipizide—Insomnia—Valproic Acid—epilepsy syndrome	6.36e-05	0.00036	CcSEcCtD
Glipizide—Oedema—Pregabalin—epilepsy syndrome	6.36e-05	0.00036	CcSEcCtD
Glipizide—Asthenia—Lamotrigine—epilepsy syndrome	6.35e-05	0.00036	CcSEcCtD
Glipizide—Dizziness—Phenytoin—epilepsy syndrome	6.35e-05	0.00036	CcSEcCtD
Glipizide—Rash—Zonisamide—epilepsy syndrome	6.32e-05	0.000358	CcSEcCtD
Glipizide—Paraesthesia—Valproic Acid—epilepsy syndrome	6.32e-05	0.000358	CcSEcCtD
Glipizide—Dermatitis—Zonisamide—epilepsy syndrome	6.31e-05	0.000358	CcSEcCtD
Glipizide—Dizziness—Oxcarbazepine—epilepsy syndrome	6.31e-05	0.000358	CcSEcCtD
Glipizide—Nausea—Diazepam—epilepsy syndrome	6.28e-05	0.000356	CcSEcCtD
Glipizide—Loss of consciousness—Gabapentin—epilepsy syndrome	6.28e-05	0.000356	CcSEcCtD
Glipizide—Headache—Zonisamide—epilepsy syndrome	6.28e-05	0.000356	CcSEcCtD
Glipizide—Dyspnoea—Valproic Acid—epilepsy syndrome	6.27e-05	0.000355	CcSEcCtD
Glipizide—Diarrhoea—Carbamazepine—epilepsy syndrome	6.27e-05	0.000355	CcSEcCtD
Glipizide—Pruritus—Lamotrigine—epilepsy syndrome	6.26e-05	0.000355	CcSEcCtD
Glipizide—Shock—Pregabalin—epilepsy syndrome	6.26e-05	0.000355	CcSEcCtD
Glipizide—Somnolence—Valproic Acid—epilepsy syndrome	6.25e-05	0.000354	CcSEcCtD
Glipizide—Thrombocytopenia—Pregabalin—epilepsy syndrome	6.23e-05	0.000353	CcSEcCtD
Glipizide—Chills—Topiramate—epilepsy syndrome	6.2e-05	0.000351	CcSEcCtD
Glipizide—Dyspepsia—Valproic Acid—epilepsy syndrome	6.19e-05	0.000351	CcSEcCtD
Glipizide—Hypertension—Gabapentin—epilepsy syndrome	6.17e-05	0.00035	CcSEcCtD
Glipizide—Hyperhidrosis—Pregabalin—epilepsy syndrome	6.15e-05	0.000348	CcSEcCtD
Glipizide—Vomiting—Clonazepam—epilepsy syndrome	6.14e-05	0.000348	CcSEcCtD
Glipizide—Decreased appetite—Valproic Acid—epilepsy syndrome	6.11e-05	0.000346	CcSEcCtD
Glipizide—Vomiting—Phenytoin—epilepsy syndrome	6.1e-05	0.000346	CcSEcCtD
Glipizide—Rash—Clonazepam—epilepsy syndrome	6.09e-05	0.000345	CcSEcCtD
Glipizide—Dermatitis—Clonazepam—epilepsy syndrome	6.09e-05	0.000345	CcSEcCtD
Glipizide—Arthralgia—Gabapentin—epilepsy syndrome	6.08e-05	0.000345	CcSEcCtD
Glipizide—Myalgia—Gabapentin—epilepsy syndrome	6.08e-05	0.000345	CcSEcCtD
Glipizide—Nausea—Felbamate—epilepsy syndrome	6.08e-05	0.000345	CcSEcCtD
Glipizide—Gastrointestinal disorder—Valproic Acid—epilepsy syndrome	6.07e-05	0.000344	CcSEcCtD
Glipizide—Vomiting—Oxcarbazepine—epilepsy syndrome	6.07e-05	0.000344	CcSEcCtD
Glipizide—Anxiety—Gabapentin—epilepsy syndrome	6.06e-05	0.000343	CcSEcCtD
Glipizide—Anorexia—Pregabalin—epilepsy syndrome	6.06e-05	0.000343	CcSEcCtD
Glipizide—Dizziness—Carbamazepine—epilepsy syndrome	6.06e-05	0.000343	CcSEcCtD
Glipizide—Diarrhoea—Lamotrigine—epilepsy syndrome	6.06e-05	0.000343	CcSEcCtD
Glipizide—Headache—Clonazepam—epilepsy syndrome	6.05e-05	0.000343	CcSEcCtD
Glipizide—Rash—Phenytoin—epilepsy syndrome	6.05e-05	0.000343	CcSEcCtD
Glipizide—Dermatitis—Phenytoin—epilepsy syndrome	6.04e-05	0.000342	CcSEcCtD
Glipizide—Rash—Oxcarbazepine—epilepsy syndrome	6.02e-05	0.000341	CcSEcCtD
Glipizide—Pain—Valproic Acid—epilepsy syndrome	6.02e-05	0.000341	CcSEcCtD
Glipizide—Constipation—Valproic Acid—epilepsy syndrome	6.02e-05	0.000341	CcSEcCtD
Glipizide—Dermatitis—Oxcarbazepine—epilepsy syndrome	6.01e-05	0.000341	CcSEcCtD
Glipizide—Headache—Phenytoin—epilepsy syndrome	6.01e-05	0.000341	CcSEcCtD
Glipizide—Erythema—Topiramate—epilepsy syndrome	6.01e-05	0.000341	CcSEcCtD
Glipizide—Discomfort—Gabapentin—epilepsy syndrome	6.01e-05	0.000341	CcSEcCtD
Glipizide—Headache—Oxcarbazepine—epilepsy syndrome	5.98e-05	0.000339	CcSEcCtD
Glipizide—Nausea—Zonisamide—epilepsy syndrome	5.95e-05	0.000337	CcSEcCtD
Glipizide—Flatulence—Topiramate—epilepsy syndrome	5.92e-05	0.000336	CcSEcCtD
Glipizide—Tension—Topiramate—epilepsy syndrome	5.9e-05	0.000334	CcSEcCtD
Glipizide—Confusional state—Gabapentin—epilepsy syndrome	5.88e-05	0.000333	CcSEcCtD
Glipizide—Dizziness—Lamotrigine—epilepsy syndrome	5.85e-05	0.000332	CcSEcCtD
Glipizide—Nervousness—Topiramate—epilepsy syndrome	5.84e-05	0.000331	CcSEcCtD
Glipizide—Oedema—Gabapentin—epilepsy syndrome	5.83e-05	0.00033	CcSEcCtD
Glipizide—Vomiting—Carbamazepine—epilepsy syndrome	5.82e-05	0.00033	CcSEcCtD
Glipizide—Feeling abnormal—Valproic Acid—epilepsy syndrome	5.8e-05	0.000328	CcSEcCtD
Glipizide—Musculoskeletal discomfort—Pregabalin—epilepsy syndrome	5.79e-05	0.000328	CcSEcCtD
Glipizide—Muscle spasms—Topiramate—epilepsy syndrome	5.78e-05	0.000327	CcSEcCtD
Glipizide—Rash—Carbamazepine—epilepsy syndrome	5.78e-05	0.000327	CcSEcCtD
Glipizide—Dermatitis—Carbamazepine—epilepsy syndrome	5.77e-05	0.000327	CcSEcCtD
Glipizide—Gastrointestinal pain—Valproic Acid—epilepsy syndrome	5.75e-05	0.000326	CcSEcCtD
Glipizide—Insomnia—Pregabalin—epilepsy syndrome	5.75e-05	0.000326	CcSEcCtD
Glipizide—Nausea—Clonazepam—epilepsy syndrome	5.74e-05	0.000325	CcSEcCtD
Glipizide—Headache—Carbamazepine—epilepsy syndrome	5.74e-05	0.000325	CcSEcCtD
Glipizide—Chlorpropamide—ABCB1—epilepsy syndrome	5.74e-05	0.0117	CrCbGaD
Glipizide—Shock—Gabapentin—epilepsy syndrome	5.74e-05	0.000325	CcSEcCtD
Glipizide—Paraesthesia—Pregabalin—epilepsy syndrome	5.71e-05	0.000324	CcSEcCtD
Glipizide—Thrombocytopenia—Gabapentin—epilepsy syndrome	5.71e-05	0.000324	CcSEcCtD
Glipizide—Nausea—Phenytoin—epilepsy syndrome	5.7e-05	0.000323	CcSEcCtD
Glipizide—Dyspnoea—Pregabalin—epilepsy syndrome	5.67e-05	0.000321	CcSEcCtD
Glipizide—Nausea—Oxcarbazepine—epilepsy syndrome	5.67e-05	0.000321	CcSEcCtD
Glipizide—Vision blurred—Topiramate—epilepsy syndrome	5.67e-05	0.000321	CcSEcCtD
Glipizide—Somnolence—Pregabalin—epilepsy syndrome	5.65e-05	0.00032	CcSEcCtD
Glipizide—Hyperhidrosis—Gabapentin—epilepsy syndrome	5.64e-05	0.000319	CcSEcCtD
Glipizide—Tremor—Topiramate—epilepsy syndrome	5.63e-05	0.000319	CcSEcCtD
Glipizide—Vomiting—Lamotrigine—epilepsy syndrome	5.63e-05	0.000319	CcSEcCtD
Glipizide—Urticaria—Valproic Acid—epilepsy syndrome	5.59e-05	0.000317	CcSEcCtD
Glipizide—Rash—Lamotrigine—epilepsy syndrome	5.58e-05	0.000316	CcSEcCtD
Glipizide—Ill-defined disorder—Topiramate—epilepsy syndrome	5.58e-05	0.000316	CcSEcCtD
Glipizide—Dermatitis—Lamotrigine—epilepsy syndrome	5.58e-05	0.000316	CcSEcCtD
Glipizide—Abdominal pain—Valproic Acid—epilepsy syndrome	5.56e-05	0.000315	CcSEcCtD
Glipizide—Anorexia—Gabapentin—epilepsy syndrome	5.56e-05	0.000315	CcSEcCtD
Glipizide—Headache—Lamotrigine—epilepsy syndrome	5.55e-05	0.000314	CcSEcCtD
Glipizide—Decreased appetite—Pregabalin—epilepsy syndrome	5.53e-05	0.000313	CcSEcCtD
Glipizide—Gastrointestinal disorder—Pregabalin—epilepsy syndrome	5.49e-05	0.000311	CcSEcCtD
Glipizide—Nausea—Carbamazepine—epilepsy syndrome	5.44e-05	0.000308	CcSEcCtD
Glipizide—Pain—Pregabalin—epilepsy syndrome	5.44e-05	0.000308	CcSEcCtD
Glipizide—Constipation—Pregabalin—epilepsy syndrome	5.44e-05	0.000308	CcSEcCtD
Glipizide—Malaise—Topiramate—epilepsy syndrome	5.42e-05	0.000307	CcSEcCtD
Glipizide—Vertigo—Topiramate—epilepsy syndrome	5.4e-05	0.000306	CcSEcCtD
Glipizide—Syncope—Topiramate—epilepsy syndrome	5.39e-05	0.000305	CcSEcCtD
Glipizide—Leukopenia—Topiramate—epilepsy syndrome	5.38e-05	0.000305	CcSEcCtD
Glipizide—Musculoskeletal discomfort—Gabapentin—epilepsy syndrome	5.31e-05	0.000301	CcSEcCtD
Glipizide—Loss of consciousness—Topiramate—epilepsy syndrome	5.28e-05	0.000299	CcSEcCtD
Glipizide—Insomnia—Gabapentin—epilepsy syndrome	5.27e-05	0.000299	CcSEcCtD
Glipizide—Nausea—Lamotrigine—epilepsy syndrome	5.26e-05	0.000298	CcSEcCtD
Glipizide—Feeling abnormal—Pregabalin—epilepsy syndrome	5.24e-05	0.000297	CcSEcCtD
Glipizide—Paraesthesia—Gabapentin—epilepsy syndrome	5.24e-05	0.000297	CcSEcCtD
Glipizide—Gastrointestinal pain—Pregabalin—epilepsy syndrome	5.2e-05	0.000295	CcSEcCtD
Glipizide—Dyspnoea—Gabapentin—epilepsy syndrome	5.2e-05	0.000295	CcSEcCtD
Glipizide—Hypertension—Topiramate—epilepsy syndrome	5.19e-05	0.000294	CcSEcCtD
Glipizide—Somnolence—Gabapentin—epilepsy syndrome	5.18e-05	0.000294	CcSEcCtD
Glipizide—Hypersensitivity—Valproic Acid—epilepsy syndrome	5.18e-05	0.000294	CcSEcCtD
Glipizide—Dyspepsia—Gabapentin—epilepsy syndrome	5.13e-05	0.000291	CcSEcCtD
Glipizide—Arthralgia—Topiramate—epilepsy syndrome	5.12e-05	0.00029	CcSEcCtD
Glipizide—Myalgia—Topiramate—epilepsy syndrome	5.12e-05	0.00029	CcSEcCtD
Glipizide—Anxiety—Topiramate—epilepsy syndrome	5.1e-05	0.000289	CcSEcCtD
Glipizide—Decreased appetite—Gabapentin—epilepsy syndrome	5.07e-05	0.000287	CcSEcCtD
Glipizide—Discomfort—Topiramate—epilepsy syndrome	5.06e-05	0.000287	CcSEcCtD
Glipizide—Urticaria—Pregabalin—epilepsy syndrome	5.05e-05	0.000286	CcSEcCtD
Glipizide—Asthenia—Valproic Acid—epilepsy syndrome	5.05e-05	0.000286	CcSEcCtD
Glipizide—Gastrointestinal disorder—Gabapentin—epilepsy syndrome	5.03e-05	0.000285	CcSEcCtD
Glipizide—Abdominal pain—Pregabalin—epilepsy syndrome	5.03e-05	0.000285	CcSEcCtD
Glipizide—Constipation—Gabapentin—epilepsy syndrome	4.99e-05	0.000283	CcSEcCtD
Glipizide—Pain—Gabapentin—epilepsy syndrome	4.99e-05	0.000283	CcSEcCtD
Glipizide—Pruritus—Valproic Acid—epilepsy syndrome	4.98e-05	0.000282	CcSEcCtD
Glipizide—Confusional state—Topiramate—epilepsy syndrome	4.95e-05	0.00028	CcSEcCtD
Glipizide—Oedema—Topiramate—epilepsy syndrome	4.91e-05	0.000278	CcSEcCtD
Glipizide—Shock—Topiramate—epilepsy syndrome	4.83e-05	0.000273	CcSEcCtD
Glipizide—Diarrhoea—Valproic Acid—epilepsy syndrome	4.81e-05	0.000273	CcSEcCtD
Glipizide—Feeling abnormal—Gabapentin—epilepsy syndrome	4.81e-05	0.000272	CcSEcCtD
Glipizide—Thrombocytopenia—Topiramate—epilepsy syndrome	4.8e-05	0.000272	CcSEcCtD
Glipizide—Gastrointestinal pain—Gabapentin—epilepsy syndrome	4.77e-05	0.00027	CcSEcCtD
Glipizide—Hyperhidrosis—Topiramate—epilepsy syndrome	4.74e-05	0.000269	CcSEcCtD
Glipizide—Hypersensitivity—Pregabalin—epilepsy syndrome	4.69e-05	0.000265	CcSEcCtD
Glipizide—Anorexia—Topiramate—epilepsy syndrome	4.68e-05	0.000265	CcSEcCtD
Glipizide—Dizziness—Valproic Acid—epilepsy syndrome	4.65e-05	0.000264	CcSEcCtD
Glipizide—Urticaria—Gabapentin—epilepsy syndrome	4.63e-05	0.000262	CcSEcCtD
Glipizide—Abdominal pain—Gabapentin—epilepsy syndrome	4.61e-05	0.000261	CcSEcCtD
Glipizide—Asthenia—Pregabalin—epilepsy syndrome	4.56e-05	0.000259	CcSEcCtD
Glipizide—Pruritus—Pregabalin—epilepsy syndrome	4.5e-05	0.000255	CcSEcCtD
Glipizide—Vomiting—Valproic Acid—epilepsy syndrome	4.47e-05	0.000253	CcSEcCtD
Glipizide—Musculoskeletal discomfort—Topiramate—epilepsy syndrome	4.47e-05	0.000253	CcSEcCtD
Glipizide—Insomnia—Topiramate—epilepsy syndrome	4.44e-05	0.000251	CcSEcCtD
Glipizide—Rash—Valproic Acid—epilepsy syndrome	4.44e-05	0.000251	CcSEcCtD
Glipizide—Dermatitis—Valproic Acid—epilepsy syndrome	4.43e-05	0.000251	CcSEcCtD
Glipizide—Headache—Valproic Acid—epilepsy syndrome	4.41e-05	0.00025	CcSEcCtD
Glipizide—Paraesthesia—Topiramate—epilepsy syndrome	4.41e-05	0.00025	CcSEcCtD
Glipizide—Dyspnoea—Topiramate—epilepsy syndrome	4.37e-05	0.000248	CcSEcCtD
Glipizide—Somnolence—Topiramate—epilepsy syndrome	4.36e-05	0.000247	CcSEcCtD
Glipizide—Diarrhoea—Pregabalin—epilepsy syndrome	4.35e-05	0.000247	CcSEcCtD
Glipizide—Dyspepsia—Topiramate—epilepsy syndrome	4.32e-05	0.000245	CcSEcCtD
Glipizide—Hypersensitivity—Gabapentin—epilepsy syndrome	4.3e-05	0.000243	CcSEcCtD
Glipizide—Decreased appetite—Topiramate—epilepsy syndrome	4.26e-05	0.000242	CcSEcCtD
Glipizide—Gastrointestinal disorder—Topiramate—epilepsy syndrome	4.24e-05	0.00024	CcSEcCtD
Glipizide—Dizziness—Pregabalin—epilepsy syndrome	4.21e-05	0.000238	CcSEcCtD
Glipizide—Pain—Topiramate—epilepsy syndrome	4.2e-05	0.000238	CcSEcCtD
Glipizide—Constipation—Topiramate—epilepsy syndrome	4.2e-05	0.000238	CcSEcCtD
Glipizide—Asthenia—Gabapentin—epilepsy syndrome	4.18e-05	0.000237	CcSEcCtD
Glipizide—Nausea—Valproic Acid—epilepsy syndrome	4.18e-05	0.000237	CcSEcCtD
Glipizide—Pruritus—Gabapentin—epilepsy syndrome	4.13e-05	0.000234	CcSEcCtD
Glipizide—Glyburide—ALB—epilepsy syndrome	4.06e-05	0.00831	CrCbGaD
Glipizide—Vomiting—Pregabalin—epilepsy syndrome	4.04e-05	0.000229	CcSEcCtD
Glipizide—Feeling abnormal—Topiramate—epilepsy syndrome	4.04e-05	0.000229	CcSEcCtD
Glipizide—Gastrointestinal pain—Topiramate—epilepsy syndrome	4.01e-05	0.000227	CcSEcCtD
Glipizide—Rash—Pregabalin—epilepsy syndrome	4.01e-05	0.000227	CcSEcCtD
Glipizide—Dermatitis—Pregabalin—epilepsy syndrome	4.01e-05	0.000227	CcSEcCtD
Glipizide—Diarrhoea—Gabapentin—epilepsy syndrome	3.99e-05	0.000226	CcSEcCtD
Glipizide—Headache—Pregabalin—epilepsy syndrome	3.98e-05	0.000226	CcSEcCtD
Glipizide—Urticaria—Topiramate—epilepsy syndrome	3.9e-05	0.000221	CcSEcCtD
Glipizide—Abdominal pain—Topiramate—epilepsy syndrome	3.88e-05	0.00022	CcSEcCtD
Glipizide—Glyburide—ABCB1—epilepsy syndrome	3.88e-05	0.00793	CrCbGaD
Glipizide—Dizziness—Gabapentin—epilepsy syndrome	3.86e-05	0.000218	CcSEcCtD
Glipizide—Nausea—Pregabalin—epilepsy syndrome	3.78e-05	0.000214	CcSEcCtD
Glipizide—Vomiting—Gabapentin—epilepsy syndrome	3.71e-05	0.00021	CcSEcCtD
Glipizide—Rash—Gabapentin—epilepsy syndrome	3.68e-05	0.000208	CcSEcCtD
Glipizide—Dermatitis—Gabapentin—epilepsy syndrome	3.67e-05	0.000208	CcSEcCtD
Glipizide—Headache—Gabapentin—epilepsy syndrome	3.65e-05	0.000207	CcSEcCtD
Glipizide—Hypersensitivity—Topiramate—epilepsy syndrome	3.61e-05	0.000205	CcSEcCtD
Glipizide—Asthenia—Topiramate—epilepsy syndrome	3.52e-05	0.000199	CcSEcCtD
Glipizide—Pruritus—Topiramate—epilepsy syndrome	3.47e-05	0.000197	CcSEcCtD
Glipizide—Nausea—Gabapentin—epilepsy syndrome	3.46e-05	0.000196	CcSEcCtD
Glipizide—Diarrhoea—Topiramate—epilepsy syndrome	3.36e-05	0.00019	CcSEcCtD
Glipizide—Dizziness—Topiramate—epilepsy syndrome	3.24e-05	0.000184	CcSEcCtD
Glipizide—Vomiting—Topiramate—epilepsy syndrome	3.12e-05	0.000177	CcSEcCtD
Glipizide—Rash—Topiramate—epilepsy syndrome	3.09e-05	0.000175	CcSEcCtD
Glipizide—Dermatitis—Topiramate—epilepsy syndrome	3.09e-05	0.000175	CcSEcCtD
Glipizide—Headache—Topiramate—epilepsy syndrome	3.07e-05	0.000174	CcSEcCtD
Glipizide—Nausea—Topiramate—epilepsy syndrome	2.91e-05	0.000165	CcSEcCtD
Glipizide—PPARG—Developmental Biology—AKT3—epilepsy syndrome	2.78e-05	0.000334	CbGpPWpGaD
Glipizide—PPARG—Gene Expression—SNRPE—epilepsy syndrome	2.72e-05	0.000327	CbGpPWpGaD
Glipizide—PPARG—Developmental Biology—ADAM10—epilepsy syndrome	2.71e-05	0.000326	CbGpPWpGaD
Glipizide—PPARG—Metabolism—ASAH1—epilepsy syndrome	2.71e-05	0.000326	CbGpPWpGaD
Glipizide—PPARG—Metabolism—STXBP1—epilepsy syndrome	2.64e-05	0.000317	CbGpPWpGaD
Glipizide—CYP2C9—Phase 1 - Functionalization of compounds—POMC—epilepsy syndrome	2.63e-05	0.000316	CbGpPWpGaD
Glipizide—ABCC8—Metabolism—KCNJ11—epilepsy syndrome	2.59e-05	0.000311	CbGpPWpGaD
Glipizide—ABCC8—Metabolism—CHRM3—epilepsy syndrome	2.59e-05	0.000311	CbGpPWpGaD
Glipizide—PPARG—Metabolism—NT5E—epilepsy syndrome	2.57e-05	0.000309	CbGpPWpGaD
Glipizide—PPARG—Metabolism—ALAD—epilepsy syndrome	2.57e-05	0.000309	CbGpPWpGaD
Glipizide—CYP2C9—Metabolism of lipids and lipoproteins—NEU1—epilepsy syndrome	2.56e-05	0.000308	CbGpPWpGaD
Glipizide—PPARG—Adipogenesis—TNF—epilepsy syndrome	2.55e-05	0.000307	CbGpPWpGaD
Glipizide—PPARG—Developmental Biology—CDC42—epilepsy syndrome	2.53e-05	0.000304	CbGpPWpGaD
Glipizide—PPARG—Generic Transcription Pathway—VDR—epilepsy syndrome	2.52e-05	0.000303	CbGpPWpGaD
Glipizide—KCNJ11—Metabolism—CHRM3—epilepsy syndrome	2.51e-05	0.000302	CbGpPWpGaD
Glipizide—CYP2C9—Metabolism of lipids and lipoproteins—HSD17B4—epilepsy syndrome	2.47e-05	0.000297	CbGpPWpGaD
Glipizide—PPARG—Metabolism—CACNA1A—epilepsy syndrome	2.45e-05	0.000295	CbGpPWpGaD
Glipizide—PPARG—Metabolism—ALDH7A1—epilepsy syndrome	2.45e-05	0.000295	CbGpPWpGaD
Glipizide—PPARG—Circadian rythm related genes—JUN—epilepsy syndrome	2.41e-05	0.000289	CbGpPWpGaD
Glipizide—PPARG—Metabolism—ST3GAL3—epilepsy syndrome	2.4e-05	0.000288	CbGpPWpGaD
Glipizide—PPARG—Metabolism—ADSL—epilepsy syndrome	2.35e-05	0.000282	CbGpPWpGaD
Glipizide—PPARG—Developmental Biology—HES1—epilepsy syndrome	2.32e-05	0.000279	CbGpPWpGaD
Glipizide—PPARG—Metabolism—GLUL—epilepsy syndrome	2.3e-05	0.000277	CbGpPWpGaD
Glipizide—PPARG—Generic Transcription Pathway—NR3C1—epilepsy syndrome	2.27e-05	0.000272	CbGpPWpGaD
Glipizide—PPARG—Metabolism—CACNA1D—epilepsy syndrome	2.26e-05	0.000272	CbGpPWpGaD
Glipizide—PPARG—Developmental Biology—FYN—epilepsy syndrome	2.26e-05	0.000271	CbGpPWpGaD
Glipizide—PPARG—Developmental Biology—MEF2C—epilepsy syndrome	2.24e-05	0.00027	CbGpPWpGaD
Glipizide—CYP2C9—Metabolism of lipids and lipoproteins—ASAH1—epilepsy syndrome	2.24e-05	0.000269	CbGpPWpGaD
Glipizide—CYP2C9—Metabolism—CA13—epilepsy syndrome	2.17e-05	0.000261	CbGpPWpGaD
Glipizide—CYP3A4—Cytochrome P450 - arranged by substrate type—POMC—epilepsy syndrome	2.14e-05	0.000257	CbGpPWpGaD
Glipizide—PPARG—Metabolism—TXNRD1—epilepsy syndrome	2.11e-05	0.000254	CbGpPWpGaD
Glipizide—ABCC8—Metabolism—ABCG2—epilepsy syndrome	2.11e-05	0.000254	CbGpPWpGaD
Glipizide—CYP3A4—Biological oxidations—CYP2C19—epilepsy syndrome	2.09e-05	0.000252	CbGpPWpGaD
Glipizide—CYP3A4—Biological oxidations—CYP11A1—epilepsy syndrome	2.08e-05	0.00025	CbGpPWpGaD
Glipizide—CYP3A4—Metapathway biotransformation—CYP2C19—epilepsy syndrome	2.07e-05	0.000248	CbGpPWpGaD
Glipizide—ABCC8—Metabolism—CYP2C19—epilepsy syndrome	2.06e-05	0.000247	CbGpPWpGaD
Glipizide—CYP3A4—Metapathway biotransformation—CYP11A1—epilepsy syndrome	2.05e-05	0.000247	CbGpPWpGaD
Glipizide—PPARG—Metabolism—AQP1—epilepsy syndrome	2.05e-05	0.000247	CbGpPWpGaD
Glipizide—KCNJ11—Metabolism—ABCG2—epilepsy syndrome	2.05e-05	0.000246	CbGpPWpGaD
Glipizide—ABCC8—Metabolism—CYP11A1—epilepsy syndrome	2.05e-05	0.000246	CbGpPWpGaD
Glipizide—KCNJ11—Metabolism—CYP2C19—epilepsy syndrome	2e-05	0.00024	CbGpPWpGaD
Glipizide—KCNJ11—Metabolism—CYP11A1—epilepsy syndrome	1.98e-05	0.000238	CbGpPWpGaD
Glipizide—PPARG—Metabolism of lipids and lipoproteins—GPX1—epilepsy syndrome	1.97e-05	0.000237	CbGpPWpGaD
Glipizide—PPARG—Gene Expression—EIF2S1—epilepsy syndrome	1.9e-05	0.000228	CbGpPWpGaD
Glipizide—CYP3A4—Biological oxidations—CYP2D6—epilepsy syndrome	1.88e-05	0.000226	CbGpPWpGaD
Glipizide—PPARG—Developmental Biology—KDR—epilepsy syndrome	1.86e-05	0.000223	CbGpPWpGaD
Glipizide—PPARG—Metabolism—CHRM3—epilepsy syndrome	1.86e-05	0.000223	CbGpPWpGaD
Glipizide—PPARG—Metabolism—KCNJ11—epilepsy syndrome	1.86e-05	0.000223	CbGpPWpGaD
Glipizide—CYP3A4—Metapathway biotransformation—CYP2D6—epilepsy syndrome	1.85e-05	0.000223	CbGpPWpGaD
Glipizide—ABCC8—Metabolism—CYP2D6—epilepsy syndrome	1.85e-05	0.000222	CbGpPWpGaD
Glipizide—PPARG—Gene Expression—HSPB1—epilepsy syndrome	1.83e-05	0.00022	CbGpPWpGaD
Glipizide—KCNJ11—Metabolism—CYP2D6—epilepsy syndrome	1.79e-05	0.000215	CbGpPWpGaD
Glipizide—PPARG—Developmental Biology—IL6ST—epilepsy syndrome	1.78e-05	0.000214	CbGpPWpGaD
Glipizide—ABCC8—Transmembrane transport of small molecules—ALB—epilepsy syndrome	1.76e-05	0.000212	CbGpPWpGaD
Glipizide—ABCC8—Metabolism—ADRA2A—epilepsy syndrome	1.76e-05	0.000211	CbGpPWpGaD
Glipizide—ABCC8—Metabolism—BCHE—epilepsy syndrome	1.75e-05	0.00021	CbGpPWpGaD
Glipizide—CYP2C9—Metabolism of lipids and lipoproteins—TXNRD1—epilepsy syndrome	1.75e-05	0.00021	CbGpPWpGaD
Glipizide—CYP3A4—Phase 1 - Functionalization of compounds—POMC—epilepsy syndrome	1.73e-05	0.000208	CbGpPWpGaD
Glipizide—PPARG—Metabolism of lipids and lipoproteins—AGT—epilepsy syndrome	1.73e-05	0.000208	CbGpPWpGaD
Glipizide—KCNJ11—Metabolism—ADRA2A—epilepsy syndrome	1.7e-05	0.000205	CbGpPWpGaD
Glipizide—KCNJ11—Metabolism—BCHE—epilepsy syndrome	1.7e-05	0.000204	CbGpPWpGaD
Glipizide—PPARG—Metabolism of lipids and lipoproteins—APOE—epilepsy syndrome	1.69e-05	0.000204	CbGpPWpGaD
Glipizide—ABCC8—Metabolism—SLC2A1—epilepsy syndrome	1.67e-05	0.000201	CbGpPWpGaD
Glipizide—ABCC8—Metabolism—PLCB1—epilepsy syndrome	1.65e-05	0.000199	CbGpPWpGaD
Glipizide—CYP2C9—Metabolism—CERS1—epilepsy syndrome	1.65e-05	0.000198	CbGpPWpGaD
Glipizide—CYP2C9—Metabolism—L2HGDH—epilepsy syndrome	1.65e-05	0.000198	CbGpPWpGaD
Glipizide—CYP2C9—Metabolism—FAR1—epilepsy syndrome	1.65e-05	0.000198	CbGpPWpGaD
Glipizide—CYP2C9—Metabolism—PDXK—epilepsy syndrome	1.65e-05	0.000198	CbGpPWpGaD
Glipizide—CYP2C9—Metabolism—ADK—epilepsy syndrome	1.65e-05	0.000198	CbGpPWpGaD
Glipizide—CYP2C9—Metabolism—GLUD1—epilepsy syndrome	1.65e-05	0.000198	CbGpPWpGaD
Glipizide—ABCC8—Metabolism—TH—epilepsy syndrome	1.65e-05	0.000198	CbGpPWpGaD
Glipizide—KCNJ11—Metabolism—SLC2A1—epilepsy syndrome	1.62e-05	0.000195	CbGpPWpGaD
Glipizide—KCNJ11—Metabolism—PLCB1—epilepsy syndrome	1.6e-05	0.000192	CbGpPWpGaD
Glipizide—KCNJ11—Metabolism—TH—epilepsy syndrome	1.6e-05	0.000192	CbGpPWpGaD
Glipizide—PPARG—Gene Expression—JUNB—epilepsy syndrome	1.53e-05	0.000184	CbGpPWpGaD
Glipizide—PPARG—Metabolism—ABCG2—epilepsy syndrome	1.51e-05	0.000182	CbGpPWpGaD
Glipizide—CYP2C9—Metabolism—GAMT—epilepsy syndrome	1.51e-05	0.000181	CbGpPWpGaD
Glipizide—CYP2C9—Metabolism—NHLRC1—epilepsy syndrome	1.51e-05	0.000181	CbGpPWpGaD
Glipizide—CYP2C9—Metabolism—PNPO—epilepsy syndrome	1.51e-05	0.000181	CbGpPWpGaD
Glipizide—CYP2C9—Metabolism—EPM2A—epilepsy syndrome	1.51e-05	0.000181	CbGpPWpGaD
Glipizide—PPARG—Metabolism—CYP2C19—epilepsy syndrome	1.48e-05	0.000177	CbGpPWpGaD
Glipizide—PPARG—Metabolism—CYP11A1—epilepsy syndrome	1.47e-05	0.000176	CbGpPWpGaD
Glipizide—PPARG—Metabolism of lipids and lipoproteins—POMC—epilepsy syndrome	1.46e-05	0.000175	CbGpPWpGaD
Glipizide—PPARG—Developmental Biology—FGF2—epilepsy syndrome	1.44e-05	0.000173	CbGpPWpGaD
Glipizide—CYP3A4—Metabolism—CA13—epilepsy syndrome	1.43e-05	0.000172	CbGpPWpGaD
Glipizide—CYP2C9—Metabolism—CA4—epilepsy syndrome	1.4e-05	0.000168	CbGpPWpGaD
Glipizide—CYP2C9—Metabolism—QDPR—epilepsy syndrome	1.4e-05	0.000168	CbGpPWpGaD
Glipizide—CYP2C9—Biological oxidations—POMC—epilepsy syndrome	1.4e-05	0.000168	CbGpPWpGaD
Glipizide—ABCC8—Metabolism—HMOX1—epilepsy syndrome	1.37e-05	0.000165	CbGpPWpGaD
Glipizide—ABCC8—Metabolism—CAT—epilepsy syndrome	1.36e-05	0.000163	CbGpPWpGaD
Glipizide—PPARG—Developmental Biology—RELA—epilepsy syndrome	1.34e-05	0.000161	CbGpPWpGaD
Glipizide—KCNJ11—Metabolism—HMOX1—epilepsy syndrome	1.33e-05	0.00016	CbGpPWpGaD
Glipizide—PPARG—Metabolism of lipids and lipoproteins—ALB—epilepsy syndrome	1.33e-05	0.00016	CbGpPWpGaD
Glipizide—PPARG—Metabolism—CYP2D6—epilepsy syndrome	1.32e-05	0.000159	CbGpPWpGaD
Glipizide—ABCC8—Metabolism—ABCB1—epilepsy syndrome	1.32e-05	0.000158	CbGpPWpGaD
Glipizide—CYP2C9—Metabolism—COX3—epilepsy syndrome	1.32e-05	0.000158	CbGpPWpGaD
Glipizide—KCNJ11—Metabolism—CAT—epilepsy syndrome	1.31e-05	0.000158	CbGpPWpGaD
Glipizide—KCNJ11—Metabolism—ABCB1—epilepsy syndrome	1.28e-05	0.000154	CbGpPWpGaD
Glipizide—PPARG—Metabolism—ADRA2A—epilepsy syndrome	1.26e-05	0.000151	CbGpPWpGaD
Glipizide—PPARG—Metabolism—BCHE—epilepsy syndrome	1.25e-05	0.000151	CbGpPWpGaD
Glipizide—CYP2C9—Metabolism—KCNB1—epilepsy syndrome	1.25e-05	0.00015	CbGpPWpGaD
Glipizide—CYP2C9—Metabolism—PFKL—epilepsy syndrome	1.25e-05	0.00015	CbGpPWpGaD
Glipizide—CYP2C9—Metabolism—SLCO1A2—epilepsy syndrome	1.25e-05	0.00015	CbGpPWpGaD
Glipizide—CYP2C9—Metabolism—CACNA2D2—epilepsy syndrome	1.25e-05	0.00015	CbGpPWpGaD
Glipizide—CYP2C9—Metabolism—SLC6A8—epilepsy syndrome	1.25e-05	0.00015	CbGpPWpGaD
Glipizide—PPARG—Gene Expression—SIRT1—epilepsy syndrome	1.23e-05	0.000148	CbGpPWpGaD
Glipizide—ABCC8—Metabolism—GPX1—epilepsy syndrome	1.23e-05	0.000147	CbGpPWpGaD
Glipizide—CYP2C9—Metabolism of lipids and lipoproteins—CYP2C19—epilepsy syndrome	1.22e-05	0.000147	CbGpPWpGaD
Glipizide—PPARG—Gene Expression—VDR—epilepsy syndrome	1.21e-05	0.000146	CbGpPWpGaD
Glipizide—CYP2C9—Metabolism of lipids and lipoproteins—CYP11A1—epilepsy syndrome	1.21e-05	0.000146	CbGpPWpGaD
Glipizide—PPARG—Metabolism—SLC2A1—epilepsy syndrome	1.2e-05	0.000144	CbGpPWpGaD
Glipizide—KCNJ11—Metabolism—GPX1—epilepsy syndrome	1.19e-05	0.000143	CbGpPWpGaD
Glipizide—PPARG—Metabolism—PLCB1—epilepsy syndrome	1.18e-05	0.000142	CbGpPWpGaD
Glipizide—PPARG—Metabolism—TH—epilepsy syndrome	1.18e-05	0.000142	CbGpPWpGaD
Glipizide—PPARG—Metabolism of lipids and lipoproteins—PTGS2—epilepsy syndrome	1.16e-05	0.00014	CbGpPWpGaD
Glipizide—PPARG—Gene Expression—H2AFX—epilepsy syndrome	1.15e-05	0.000138	CbGpPWpGaD
Glipizide—CYP2C9—Metabolism—ATIC—epilepsy syndrome	1.14e-05	0.000137	CbGpPWpGaD
Glipizide—CYP2C9—Metabolism—UPB1—epilepsy syndrome	1.14e-05	0.000137	CbGpPWpGaD
Glipizide—CYP2C9—Metabolism—NEU1—epilepsy syndrome	1.14e-05	0.000137	CbGpPWpGaD
Glipizide—PPARG—Developmental Biology—MMP9—epilepsy syndrome	1.14e-05	0.000137	CbGpPWpGaD
Glipizide—PPARG—Gene Expression—YWHAZ—epilepsy syndrome	1.11e-05	0.000133	CbGpPWpGaD
Glipizide—CYP2C9—Metabolism—HSD17B4—epilepsy syndrome	1.1e-05	0.000132	CbGpPWpGaD
Glipizide—PPARG—Gene Expression—NR3C1—epilepsy syndrome	1.09e-05	0.000131	CbGpPWpGaD
Glipizide—CYP3A4—Metabolism—CERS1—epilepsy syndrome	1.09e-05	0.000131	CbGpPWpGaD
Glipizide—CYP3A4—Metabolism—FAR1—epilepsy syndrome	1.09e-05	0.000131	CbGpPWpGaD
Glipizide—CYP3A4—Metabolism—ADK—epilepsy syndrome	1.09e-05	0.000131	CbGpPWpGaD
Glipizide—CYP3A4—Metabolism—GLUD1—epilepsy syndrome	1.09e-05	0.000131	CbGpPWpGaD
Glipizide—CYP3A4—Metabolism—L2HGDH—epilepsy syndrome	1.09e-05	0.000131	CbGpPWpGaD
Glipizide—CYP3A4—Metabolism—PDXK—epilepsy syndrome	1.09e-05	0.000131	CbGpPWpGaD
Glipizide—ABCC8—Metabolism—AGT—epilepsy syndrome	1.07e-05	0.000129	CbGpPWpGaD
Glipizide—CYP2C9—Metabolism—PPP1R3C—epilepsy syndrome	1.06e-05	0.000128	CbGpPWpGaD
Glipizide—CYP2C9—Metabolism—GBE1—epilepsy syndrome	1.06e-05	0.000128	CbGpPWpGaD
Glipizide—ABCC8—Metabolism—APOE—epilepsy syndrome	1.05e-05	0.000127	CbGpPWpGaD
Glipizide—PPARG—Developmental Biology—SRC—epilepsy syndrome	1.05e-05	0.000126	CbGpPWpGaD
Glipizide—KCNJ11—Metabolism—AGT—epilepsy syndrome	1.04e-05	0.000125	CbGpPWpGaD
Glipizide—CYP2C9—Metabolism of lipids and lipoproteins—BCHE—epilepsy syndrome	1.04e-05	0.000125	CbGpPWpGaD
Glipizide—PPARG—Developmental Biology—VEGFA—epilepsy syndrome	1.02e-05	0.000123	CbGpPWpGaD
Glipizide—KCNJ11—Metabolism—APOE—epilepsy syndrome	1.02e-05	0.000123	CbGpPWpGaD
Glipizide—CYP2C9—Metabolism—ASAH1—epilepsy syndrome	9.98e-06	0.00012	CbGpPWpGaD
Glipizide—CYP3A4—Metabolism—NHLRC1—epilepsy syndrome	9.93e-06	0.000119	CbGpPWpGaD
Glipizide—CYP3A4—Metabolism—PNPO—epilepsy syndrome	9.93e-06	0.000119	CbGpPWpGaD
Glipizide—CYP3A4—Metabolism—EPM2A—epilepsy syndrome	9.93e-06	0.000119	CbGpPWpGaD
Glipizide—CYP3A4—Metabolism—GAMT—epilepsy syndrome	9.93e-06	0.000119	CbGpPWpGaD
Glipizide—PPARG—Metabolism—HMOX1—epilepsy syndrome	9.84e-06	0.000118	CbGpPWpGaD
Glipizide—PPARG—Metabolism—CAT—epilepsy syndrome	9.71e-06	0.000117	CbGpPWpGaD
Glipizide—CYP2C9—Metabolism—STXBP1—epilepsy syndrome	9.71e-06	0.000117	CbGpPWpGaD
Glipizide—CYP2C9—Metabolism—NT5E—epilepsy syndrome	9.46e-06	0.000114	CbGpPWpGaD
Glipizide—CYP2C9—Metabolism—ALAD—epilepsy syndrome	9.46e-06	0.000114	CbGpPWpGaD
Glipizide—PPARG—Metabolism—ABCB1—epilepsy syndrome	9.45e-06	0.000114	CbGpPWpGaD
Glipizide—CYP3A4—Metabolism—QDPR—epilepsy syndrome	9.23e-06	0.000111	CbGpPWpGaD
Glipizide—CYP3A4—Metabolism—CA4—epilepsy syndrome	9.23e-06	0.000111	CbGpPWpGaD
Glipizide—CYP3A4—Biological oxidations—POMC—epilepsy syndrome	9.21e-06	0.000111	CbGpPWpGaD
Glipizide—ABCC8—Metabolism—POMC—epilepsy syndrome	9.04e-06	0.000109	CbGpPWpGaD
Glipizide—CYP2C9—Metabolism—CACNA1A—epilepsy syndrome	9.02e-06	0.000108	CbGpPWpGaD
Glipizide—CYP2C9—Metabolism—ALDH7A1—epilepsy syndrome	9.02e-06	0.000108	CbGpPWpGaD
Glipizide—CYP2C9—Metabolism—ST3GAL3—epilepsy syndrome	8.83e-06	0.000106	CbGpPWpGaD
Glipizide—PPARG—Metabolism—GPX1—epilepsy syndrome	8.78e-06	0.000106	CbGpPWpGaD
Glipizide—PPARG—Developmental Biology—TNF—epilepsy syndrome	8.78e-06	0.000105	CbGpPWpGaD
Glipizide—KCNJ11—Metabolism—POMC—epilepsy syndrome	8.77e-06	0.000105	CbGpPWpGaD
Glipizide—CYP3A4—Metabolism—COX3—epilepsy syndrome	8.68e-06	0.000104	CbGpPWpGaD
Glipizide—CYP2C9—Metabolism—ADSL—epilepsy syndrome	8.65e-06	0.000104	CbGpPWpGaD
Glipizide—CYP2C9—Metabolism—GLUL—epilepsy syndrome	8.48e-06	0.000102	CbGpPWpGaD
Glipizide—CYP2C9—Metabolism—CACNA1D—epilepsy syndrome	8.33e-06	0.0001	CbGpPWpGaD
Glipizide—ABCC8—Metabolism—ALB—epilepsy syndrome	8.25e-06	9.91e-05	CbGpPWpGaD
Glipizide—CYP3A4—Metabolism—KCNB1—epilepsy syndrome	8.23e-06	9.89e-05	CbGpPWpGaD
Glipizide—CYP3A4—Metabolism—SLCO1A2—epilepsy syndrome	8.23e-06	9.89e-05	CbGpPWpGaD
Glipizide—CYP3A4—Metabolism—CACNA2D2—epilepsy syndrome	8.23e-06	9.89e-05	CbGpPWpGaD
Glipizide—CYP3A4—Metabolism—PFKL—epilepsy syndrome	8.23e-06	9.89e-05	CbGpPWpGaD
Glipizide—CYP3A4—Metabolism—SLC6A8—epilepsy syndrome	8.23e-06	9.89e-05	CbGpPWpGaD
Glipizide—KCNJ11—Metabolism—ALB—epilepsy syndrome	8e-06	9.61e-05	CbGpPWpGaD
Glipizide—CYP2C9—Metabolism—TXNRD1—epilepsy syndrome	7.79e-06	9.36e-05	CbGpPWpGaD
Glipizide—PPARG—Metabolism—AGT—epilepsy syndrome	7.7e-06	9.26e-05	CbGpPWpGaD
Glipizide—CYP2C9—Metabolism—AQP1—epilepsy syndrome	7.56e-06	9.09e-05	CbGpPWpGaD
Glipizide—PPARG—Metabolism—APOE—epilepsy syndrome	7.55e-06	9.07e-05	CbGpPWpGaD
Glipizide—CYP3A4—Metabolism—UPB1—epilepsy syndrome	7.53e-06	9.05e-05	CbGpPWpGaD
Glipizide—CYP3A4—Metabolism—NEU1—epilepsy syndrome	7.53e-06	9.05e-05	CbGpPWpGaD
Glipizide—CYP3A4—Metabolism—ATIC—epilepsy syndrome	7.53e-06	9.05e-05	CbGpPWpGaD
Glipizide—CYP2C9—Metabolism of lipids and lipoproteins—GPX1—epilepsy syndrome	7.26e-06	8.73e-05	CbGpPWpGaD
Glipizide—CYP3A4—Metabolism—HSD17B4—epilepsy syndrome	7.25e-06	8.71e-05	CbGpPWpGaD
Glipizide—ABCC8—Metabolism—PTGS2—epilepsy syndrome	7.21e-06	8.67e-05	CbGpPWpGaD
Glipizide—CYP3A4—Metabolism—PPP1R3C—epilepsy syndrome	7e-06	8.41e-05	CbGpPWpGaD
Glipizide—CYP3A4—Metabolism—GBE1—epilepsy syndrome	7e-06	8.41e-05	CbGpPWpGaD
Glipizide—KCNJ11—Metabolism—PTGS2—epilepsy syndrome	7e-06	8.41e-05	CbGpPWpGaD
Glipizide—CYP2C9—Metabolism—KCNJ11—epilepsy syndrome	6.84e-06	8.22e-05	CbGpPWpGaD
Glipizide—CYP2C9—Metabolism—CHRM3—epilepsy syndrome	6.84e-06	8.22e-05	CbGpPWpGaD
Glipizide—CYP3A4—Metabolism—ASAH1—epilepsy syndrome	6.58e-06	7.91e-05	CbGpPWpGaD
Glipizide—PPARG—Developmental Biology—AKT1—epilepsy syndrome	6.53e-06	7.85e-05	CbGpPWpGaD
Glipizide—PPARG—Metabolism—POMC—epilepsy syndrome	6.48e-06	7.79e-05	CbGpPWpGaD
Glipizide—CYP3A4—Metabolism—STXBP1—epilepsy syndrome	6.4e-06	7.69e-05	CbGpPWpGaD
Glipizide—CYP2C9—Metabolism of lipids and lipoproteins—AGT—epilepsy syndrome	6.37e-06	7.65e-05	CbGpPWpGaD
Glipizide—CYP2C9—Metabolism of lipids and lipoproteins—APOE—epilepsy syndrome	6.24e-06	7.5e-05	CbGpPWpGaD
Glipizide—CYP3A4—Metabolism—NT5E—epilepsy syndrome	6.24e-06	7.5e-05	CbGpPWpGaD
Glipizide—CYP3A4—Metabolism—ALAD—epilepsy syndrome	6.24e-06	7.5e-05	CbGpPWpGaD
Glipizide—CYP3A4—Metabolism—CACNA1A—epilepsy syndrome	5.95e-06	7.15e-05	CbGpPWpGaD
Glipizide—CYP3A4—Metabolism—ALDH7A1—epilepsy syndrome	5.95e-06	7.15e-05	CbGpPWpGaD
Glipizide—PPARG—Metabolism—ALB—epilepsy syndrome	5.91e-06	7.1e-05	CbGpPWpGaD
Glipizide—CYP3A4—Metabolism—ST3GAL3—epilepsy syndrome	5.82e-06	7e-05	CbGpPWpGaD
Glipizide—CYP3A4—Metabolism—ADSL—epilepsy syndrome	5.7e-06	6.86e-05	CbGpPWpGaD
Glipizide—CYP3A4—Metabolism—GLUL—epilepsy syndrome	5.59e-06	6.72e-05	CbGpPWpGaD
Glipizide—CYP2C9—Metabolism—ABCG2—epilepsy syndrome	5.57e-06	6.7e-05	CbGpPWpGaD
Glipizide—CYP3A4—Metabolism—CACNA1D—epilepsy syndrome	5.49e-06	6.6e-05	CbGpPWpGaD
Glipizide—CYP2C9—Metabolism—CYP2C19—epilepsy syndrome	5.43e-06	6.53e-05	CbGpPWpGaD
Glipizide—CYP2C9—Metabolism—CYP11A1—epilepsy syndrome	5.4e-06	6.49e-05	CbGpPWpGaD
Glipizide—CYP2C9—Metabolism of lipids and lipoproteins—POMC—epilepsy syndrome	5.36e-06	6.44e-05	CbGpPWpGaD
Glipizide—PPARG—Metabolism—PTGS2—epilepsy syndrome	5.17e-06	6.21e-05	CbGpPWpGaD
Glipizide—CYP3A4—Metabolism—TXNRD1—epilepsy syndrome	5.14e-06	6.17e-05	CbGpPWpGaD
Glipizide—CYP3A4—Metabolism—AQP1—epilepsy syndrome	4.99e-06	5.99e-05	CbGpPWpGaD
Glipizide—CYP2C9—Metabolism of lipids and lipoproteins—ALB—epilepsy syndrome	4.89e-06	5.87e-05	CbGpPWpGaD
Glipizide—CYP2C9—Metabolism—CYP2D6—epilepsy syndrome	4.87e-06	5.86e-05	CbGpPWpGaD
Glipizide—CYP2C9—Metabolism—ADRA2A—epilepsy syndrome	4.64e-06	5.58e-05	CbGpPWpGaD
Glipizide—CYP2C9—Metabolism—BCHE—epilepsy syndrome	4.62e-06	5.55e-05	CbGpPWpGaD
Glipizide—CYP3A4—Metabolism—KCNJ11—epilepsy syndrome	4.51e-06	5.42e-05	CbGpPWpGaD
Glipizide—CYP3A4—Metabolism—CHRM3—epilepsy syndrome	4.51e-06	5.42e-05	CbGpPWpGaD
Glipizide—CYP2C9—Metabolism—SLC2A1—epilepsy syndrome	4.41e-06	5.3e-05	CbGpPWpGaD
Glipizide—CYP2C9—Metabolism—PLCB1—epilepsy syndrome	4.36e-06	5.24e-05	CbGpPWpGaD
Glipizide—CYP2C9—Metabolism—TH—epilepsy syndrome	4.34e-06	5.22e-05	CbGpPWpGaD
Glipizide—CYP2C9—Metabolism of lipids and lipoproteins—PTGS2—epilepsy syndrome	4.28e-06	5.14e-05	CbGpPWpGaD
Glipizide—CYP3A4—Metabolism—ABCG2—epilepsy syndrome	3.68e-06	4.42e-05	CbGpPWpGaD
Glipizide—ABCC8—Metabolism—AKT1—epilepsy syndrome	3.63e-06	4.36e-05	CbGpPWpGaD
Glipizide—CYP2C9—Metabolism—HMOX1—epilepsy syndrome	3.62e-06	4.36e-05	CbGpPWpGaD
Glipizide—CYP3A4—Metabolism—CYP2C19—epilepsy syndrome	3.58e-06	4.31e-05	CbGpPWpGaD
Glipizide—CYP2C9—Metabolism—CAT—epilepsy syndrome	3.58e-06	4.3e-05	CbGpPWpGaD
Glipizide—CYP3A4—Metabolism—CYP11A1—epilepsy syndrome	3.56e-06	4.28e-05	CbGpPWpGaD
Glipizide—KCNJ11—Metabolism—AKT1—epilepsy syndrome	3.52e-06	4.23e-05	CbGpPWpGaD
Glipizide—CYP2C9—Metabolism—ABCB1—epilepsy syndrome	3.48e-06	4.18e-05	CbGpPWpGaD
Glipizide—PPARG—Gene Expression—AKT1—epilepsy syndrome	3.34e-06	4.02e-05	CbGpPWpGaD
Glipizide—CYP2C9—Metabolism—GPX1—epilepsy syndrome	3.23e-06	3.89e-05	CbGpPWpGaD
Glipizide—CYP3A4—Metabolism—CYP2D6—epilepsy syndrome	3.21e-06	3.86e-05	CbGpPWpGaD
Glipizide—CYP3A4—Metabolism—ADRA2A—epilepsy syndrome	3.06e-06	3.68e-05	CbGpPWpGaD
Glipizide—CYP3A4—Metabolism—BCHE—epilepsy syndrome	3.05e-06	3.66e-05	CbGpPWpGaD
Glipizide—CYP3A4—Metabolism—SLC2A1—epilepsy syndrome	2.91e-06	3.49e-05	CbGpPWpGaD
Glipizide—CYP3A4—Metabolism—PLCB1—epilepsy syndrome	2.87e-06	3.46e-05	CbGpPWpGaD
Glipizide—CYP3A4—Metabolism—TH—epilepsy syndrome	2.86e-06	3.44e-05	CbGpPWpGaD
Glipizide—CYP2C9—Metabolism—AGT—epilepsy syndrome	2.84e-06	3.41e-05	CbGpPWpGaD
Glipizide—CYP2C9—Metabolism—APOE—epilepsy syndrome	2.78e-06	3.34e-05	CbGpPWpGaD
Glipizide—PPARG—Metabolism—AKT1—epilepsy syndrome	2.6e-06	3.12e-05	CbGpPWpGaD
Glipizide—CYP3A4—Metabolism—HMOX1—epilepsy syndrome	2.39e-06	2.87e-05	CbGpPWpGaD
Glipizide—CYP2C9—Metabolism—POMC—epilepsy syndrome	2.39e-06	2.87e-05	CbGpPWpGaD
Glipizide—CYP3A4—Metabolism—CAT—epilepsy syndrome	2.36e-06	2.83e-05	CbGpPWpGaD
Glipizide—CYP3A4—Metabolism—ABCB1—epilepsy syndrome	2.29e-06	2.76e-05	CbGpPWpGaD
Glipizide—CYP2C9—Metabolism—ALB—epilepsy syndrome	2.18e-06	2.62e-05	CbGpPWpGaD
Glipizide—CYP3A4—Metabolism—GPX1—epilepsy syndrome	2.13e-06	2.56e-05	CbGpPWpGaD
Glipizide—CYP2C9—Metabolism—PTGS2—epilepsy syndrome	1.9e-06	2.29e-05	CbGpPWpGaD
Glipizide—CYP3A4—Metabolism—AGT—epilepsy syndrome	1.87e-06	2.25e-05	CbGpPWpGaD
Glipizide—CYP3A4—Metabolism—APOE—epilepsy syndrome	1.83e-06	2.2e-05	CbGpPWpGaD
Glipizide—CYP3A4—Metabolism—POMC—epilepsy syndrome	1.57e-06	1.89e-05	CbGpPWpGaD
Glipizide—CYP3A4—Metabolism—ALB—epilepsy syndrome	1.44e-06	1.73e-05	CbGpPWpGaD
Glipizide—CYP3A4—Metabolism—PTGS2—epilepsy syndrome	1.26e-06	1.51e-05	CbGpPWpGaD
Glipizide—CYP2C9—Metabolism—AKT1—epilepsy syndrome	9.57e-07	1.15e-05	CbGpPWpGaD
Glipizide—CYP3A4—Metabolism—AKT1—epilepsy syndrome	6.31e-07	7.59e-06	CbGpPWpGaD
